These findings demonstrate that lack of MAX expression is a potential poor prognostic biomarker in ALCL and a candidate marker for differential diagnosis of ALCL and PTCL-NOS. This evidence concerns the gene MAX and mature T-cell and NK-cell non-Hodgkin lymphoma.